Press releases
Update on decellularized homografts for double semilunar valve replacement
Bobylev et al published an update on the Hannover Medical School experience in simultaneous double semilunar valve replacement in congenital heart disease. Decellularized homografts were used for double valve replacement as well...
Long decellularized valved aortic homografts restore normal hemodynamics
A 4D-Flow CMR study on decellularized allografts for extended aortic valve replacement was recently published within the European Journal of Cardiothoracic Surgery. Cvitkovic et al. demonstrate within this publication near...
Newly developed method helps to quantify the residual immunogenic potential of decellularized human heart valves
Dot-blot techniques demonstrate highly individual immune response towards decellularized homografts - Results published Open Access in the European Journal of Cardio-Thoracic-Surgery
Results of the first 106 pediatric patients published– Open Acces in the European Journal of Cardio-Thoracic Surgery
The results of the first 106 pediatric implantations of a decellularised aortic homograft have been published now and are available Open Access under this permanent link:
Initial results of the ARISE trial published in the European Journal of Cardio-Thoracic Surgery – Open Acces
Initial results from the ARISE trial, a prospective, single-arm European study on decellularized allografts for aortic valve replacement now have been published and are available Open Access under this permanent link:
Presentation of the early ARISE results at the 2019 Meeting of the European Association for Cardio-Thoracic-Surgery (EACTS) Saturday 5th of October in Lisbon, Portugal
Results for pediatric aortic valve replacement using cell-free homografts will be presented as well at the EACTS 2019 [more]
ARISE closing meeting held on 1st of March 2019 in Hannover - Early results from the prospective European trial on cell-free allografts for aortic valve replacement
Aortic valve replacement (AVR) in children and young adult patients still constitutes a major problem as these young individuals face a difficult choice between a complex, multi-valve procedure such as the Ross-procedure and the... [more]
Patient lecture and seminar on regenerative heart valves and stem cell therapy options - 30.03.2019 in the Hannover Zoo
Patientenseminar: Regenerative Therapien und Stammzelltherapie bei angeborenen Herzfehlern – geht das schon? [more]
ARISE Trial inclusion completed – calculated sample size exceeded by participating hospitals
120 implantations was the calculated sample size for the ARISE study, which is trialing a novel type of graft – cell-free aortic homografts- for the replacement of aortic valves. 8 participating hospitals managed to include 138... [more]
World Heart Day Information by the European Commission – Rebuilding young lives with cell-free heart valves
The ARISE project has been chosen as a theme for the World Heart Day information campaign by the European Commission. The report can be found here. [more]
Neuer Artikel in der HAZ
Hier finden Sie den Artikel Wie eine Gewebespende diesem 26-Jährigen das Leben rettete vom 6. Juni 2018. [more]
Report on the training workshop for surgeons
Please find the Report on the training workshop for surgeons in Barcelona hier. [more]
ARISE clinical study presented at the 31st Annual Meeting of the European Association For Cardio-Thoracic Surgery (EACTS) 2017 in Vienna
Brazilian group reports results of decellularised allografts used for RVOT construction during the ROSS operation Training workshop for young surgeons held in Barcelona in November 2017 Prof. Dr. Samir Sarikouch presented the... [more]
ARISE Clinical Trial half-time on the road
Patient inclusion to the ARISE trial is proceeding nicely. Figure 1 is showing the numbers of patients operated within the trial already as well as the number of scheduled operations. Therefore the ARISE consortium is confident... [more]